peptide radionuclide receptor therapy

M. Sue O'Dorisio

University of Iowa Holden Comprehensive Cancer Center is the first U.S. cancer center to be designated a Neuroendocrine Tumor Center of Excellence by the European Neuroendocrine Tumor Society (ENETS). In making the award to the Iowa team in early March, ENETS listed its criteria for the distinction, including The Holden team’s advanced interdisciplinary approach for diagnosing neuroendocrine tumor (NET) patients The quality and breadth of the team’s medical treatments for NETS

Dr. Thor & Dr. Tuba present The Future of PRRT & The Team Approach

On January 14, 2018, Dr. Thor Halfdanarson and Dr. A. Tuba Kendi from Mayo Clinic Rochester presented to Northwoods NETS. Dr. Tuba, a radiologist from Mayo, has been fronting the Gallium-68 PET/MRI scan center that has been helping detect and diagnose neuroendocrine tumor patients. She is now at the forefront the PRRT (peptide receptor radionuclide therapy) at the Rochester clinic. Dr. Thor presented his vision for the newly designated Neuroendocrine

Part Ten: Round Three was a doozy

I left for Europe a week earlier this time to visit Munich with my sister and Oktoberfest. It was actually her first ever trip to Europe and even though I did round two by myself, it was nice to have the company. We really only had two and a half days in Munich, one day at the festival, one day at Dachau Concentration Camp and the first half day to

If you are considering PRRT (Peptide Receptor Radionuclide Therapy) you know that it is still not available in the United States in 2016. We are hopeful that it will pass FDA regulation in 2017, but, even then, it may take six months or more before insurers have the codes and are no longer considering it “investigational.” If you need treatment, do not delay waiting for it’s possible FDA approval. We Ed is a blogger who has detailed out his journey with Carcinoid Cancer. He recently underwent three rounds of PRRT at Houston’s MD Anderson. While this treatment is not approved in the US at the time of writing, it is allowable under the “right to try” treatments. He has posted details of his first, second and third treatments. Flush Poop PRRT Polly Newman wrote an excellent and detailed account of